Clinical Trials Directory

Trials / Unknown

UnknownNCT04156568

A Multicentre, Cohort Study of Screening and Preventive Intervention for Latent Tuberculosis Infection in Children

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
1,000 (estimated)
Sponsor
Beijing Children's Hospital · Academic / Other
Sex
All
Age
1 Day – 18 Years
Healthy volunteers
Not accepted

Summary

The management of latent Mycobacterium tuberculosis infection is a new priority action for the WHO End Tuberculosis (TB) Strategy. However, national guidelines on latent tuberculosis infection testing and treatment have not yet been developed in children of China. Here, we present the results from the 3-year follow-up of a study that aimed to track the development of active disease in individuals with latent tuberculosis infection, identify priority populations for latent infection management, and explore the most suitable latent infection diagnostic approach.

Detailed description

1\. Baseline analysis of a population-based, multicentre, prospective cohort study 1. A baseline survey of a population-based, multicentre, prospective cohort study were took in children (≤18). 2. Eligible participants were identifi ed by door-to-door survey with a household sampling design. 3. Participants were screened for active tuberculosis and history of tuberculosis then used a tuberculin skin test and an interferon-γ release assay (QuantiFERON \[QFT\]) to test for latent infection. 2\. Incidence of active tuberculosis in individuals with latent tuberculosis infection in children of China under different treatment regimens 1. Individuals who had tuberculosis infection at baseline (QFT-positivity or TST tuberculin reaction size \[induration\] of ≥10 mm) were divided and treatment with different therapeutic schedule. 2. Follow-up study were conducted to assess the proportion of latent TB infection converted to active TB

Conditions

Interventions

TypeNameDescription
DRUGINH、RFT6INH 10mg/kg 3INH+RFT 15mg/kg

Timeline

Start date
2018-11-01
Primary completion
2021-09-01
Completion
2021-12-31
First posted
2019-11-07
Last updated
2019-11-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04156568. Inclusion in this directory is not an endorsement.